| Antiplatelet Therapy to Prevent Stroke in African Americans |
|
4 |
 |
| Aspirin Versus Anticoagulants in Symptomatic Intracranial Stenosis. |
AVASIS |
N/A |
 |
| Antiphospholipid Antibodies and Stroke Study |
APASS |
N/A |
 |
| Aspirin and Carotid Endarterectomy Trial |
ACE |
N/A |
 |
| Clopidogrel vs. Aspirin in Patients at Risk of Ischemic Events |
CAPRIE |
3 |
 |
| European / Australasian Stroke Prevention in Reversible Ischaemia Trial |
ESPRIT |
N/A |
 |
| European Stroke Prevention Study |
ESPS-2 |
N/A |
 |
| Patent Foramen Ovale in Cryptogenic Stroke Study |
PICSS |
4 |
 |
| Stroke Prevention in Atrial Fibrillation III |
SPAF III |
N/A |
 |
| Stroke Prevention in Reversible Ischemia Trial |
SPIRIT |
3 |
 |
| Triflusal vs Aspirin for the Prevention of Infarction: Randomized Stroke Study |
TAPIRSS |
3 |
 |
| Warfarin Versus Aspirin Recurrent Stroke Study |
|
3 |
 |
| Anturane TIA Italian Study |
ATIAIS |
N/A |
 |
| Triflusal vs Acetylsalicylic Acid in Secondary Prevention of Cerebral Infarction |
TACIP |
3 |
 |
| Warfarin-Aspirin Symptomatic Intracranial Disease Study |
WASID |
3 |
 |
| United Kingdom Transient Ischaemic Attack Aspirin Trial |
UK-TIA |
N/A |
 |
| Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study |
AFASAK II |
3 |
 |
| Secondary Prevention of Small Subcortical Strokes Trial |
SPS3 |
3 |
 |
| Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial |
WARCEF |
3 |
 |
| Carotid Artery Stenosis with Asymptomatic Narrowing: Operation Versus Aspirin |
CASANOVA |
N/A |
 |
| Heparin in Acute Embolic Stroke Trial |
HAEST |
3 |
 |
| Warfarin-Aspirin Symptomatic Intracranial Disease Study - Retrospective |
WASID-R |
N/A |
 |
| Recurrent Carotid Stenosis |
|
2 |
 |
| European Atrial Fibrillation Trial |
EAFT |
N/A |
 |
| Danish very-low-dose aspirin after carotid endarterectomy trial |
|
N/A |
 |
| Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in stroke prevention |
|
N/A |
 |
| Swedish Cooperative Study |
|
N/A |
 |
| Persantine Aspirin Trial |
|
N/A |
 |
| Controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia |
AICLA |
N/A |
 |
| Aspirin and sulfinpyrazone in threatened stroke |
|
N/A |
 |
| Aspirin in Transient Ischemic Attacks |
AITIA |
N/A |
 |
| Danish Cooperative Study |
|
N/A |
 |
| Dutch TIA Study |
Dutch TIA |
N/A |
 |
| Management of ATherothrombosis with Clopidogrel in High-risk patients with recent TIA or ischemic stroke |
MATCH |
N/A |
 |
| Ticlopidine Aspirin Stroke Study |
|
N/A |
 |
| Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks |
|
N/A |
 |
| Aspirin Dose Optimized in Non-Cardioembolic Ischemic Stroke |
ADONIS |
N/A |
 |
| Aortic Arch Related Cerebral Hazard Trial (ARCH) |
ARCH |
3 |
 |
| RESPECT PFO Clinical Trial |
|
2 |
 |
| Fast Assessment of Stroke and Transient ischemic attack to prevent Early Recurrence - Pilot Study |
FASTER |
N/A |
 |
| Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis |
CARESS |
N/A |
 |
| Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) |
|
3 |
 |
| Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 |
ASPECT-2 |
N/A |
 |
| Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study |
AFASAK I |
N/A |
 |
| Japanese Primary Prevention Project With Aspirin |
|
4 |
 |
| Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) |
COGENT-1 |
3 |
 |
| Birmingham Atrial Fibrillation Treatment of the Aged |
BAFTA |
N/A |
 |
| Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis |
|
3 |
 |
| Clopidogrel and Aspirin versus Aspirin Alone in Stroke Patients |
PLUTO |
N/A |
 |
| STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery |
STRATAGEM |
4 |
 |
| Amplified Benefit of Clopidogrel Versus Aspirin in Patients With Diabetes Mellitus |
|
N/A |
 |
| National Study for Prevention of Embolism in Atrial Fibrillation |
NASPEAF |
N/A |
 |
| Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) |
|
3 |
 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) |
|
3 |
 |
| Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis. |
|
N/A |
 |
| ASCEND: A Study of Cardiovascular Events iN Diabetes |
|
4 |
 |
| Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II |
TOSS-2 |
4 |
 |
| JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme |
|
3 |
 |
| A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease |
ARRIVE |
3 |
 |
| Long Term Open Follow-up With H376/95 vs. Warfarin |
|
2 |
 |
| The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol |
4C-DES |
N/A |
 |
| Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke |
|
3 |
 |
| Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS) |
RAPCAPS |
4 |
 |
| Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial |
|
4 |
 |
| Dual antiplatelet therapy in the acute phase following stroke and transient ischaemic attack (TIA): which is the best regimen? |
AMBDAP |
N/A |
 |
| Standard Medical Management in Secondary Prevention of Ischemic Stroke in China |
SMART |
N/A |
 |